## Analyzing TG Therapeutics’ RSI
TG Therapeutics Inc (TGTX) dipped into oversold territory on Monday with an RSI reading of 29.8, signaling potential opportunity. The company’s stock reached as low as $21.16 per share, highlighting a moment of market fear.

## Understanding Relative Strength Index (RSI)
The Relative Strength Index (RSI) measures stock momentum from 0 to 100. When RSI falls below 30, it indicates an oversold condition. In comparison, the RSI for the S&P 500 ETF (SPY) stands at 51.8, showing a different market sentiment.

## Technical Analysis Insights
For investors, TGTX’s RSI of 29.8 could suggest the end of heavy selling pressure, opening doors for potential buying opportunities. By evaluating the one-year chart performance, one can see TGTX’s fluctuation from a low of $6.46 to a high of $26.41 per share, closing at $21.31.


## Conclusion
While market fluctuations can be daunting, understanding technical indicators like RSI can uncover valuable investment moments. As Warren Buffett advises, seizing opportunity amidst fear can lead to profitable outcomes. Is TG Therapeutics poised for a rebound amidst oversold conditions? Time and market dynamics will tell.

Find out more about 9 other oversold stocks that may pique your interest.